[PDF] Top 20 Detection of kras mutation in circulating free dna (cfdna)
Has 10000 "Detection of kras mutation in circulating free dna (cfdna)" found on our website. Below are the top 20 most common "Detection of kras mutation in circulating free dna (cfdna)".
Detection of kras mutation in circulating free dna (cfdna)
... for cfDNA in cancer diagnosis and prognosis for example, cfDNA can be used to detect somatic alterations when biopsies are not ...tumor DNA when the exact position of a suspected primary lesion is ... See full document
8
Emerging concepts in liquid biopsies
... of circulating free DNA (cfDNA) found in the plasma component of blood to evaluate the current status of the cancer ...of cfDNA in 1948, nu- merous research efforts have attempted to ... See full document
12
KRAS mutations in blood circulating cell-free DNA: a pancreatic cancer case-control study
... detectable cfDNA KRAS mutations tended to increase with more advanced stages and that KRAS allelic fractions were higher in cases than controls or in patients with chronic pancreatitis [23, ... See full document
14
Cell-free DNA in non-small cell lung cancer
... of cfDNA in blood was reported by Mandel and Metais in 1948 (3, ...then, cfDNA has found applications in many disciplines of medicine but particularly in the evaluation of foetal DNA in the ... See full document
7
Release of circulating tumor cells and cell-free nucleic acids is an infrequent event in synovial sarcoma: liquid biopsy analysis of 15 patients diagnosed with synovial sarcoma
... metastases. Detection of CTCs has been examined across a wide spectrum of tumor types, but most commonly in carcinomas of the breast, lung and colon, as well as in melanoma ...tumor detection and follow-up ... See full document
7
Noninvasive detection of tumor-associated mutations from circulating cell-free DNA in hepatocellular carcinoma patients by targeted deep sequencing
... Between December 2013 and August 2014, a total of 41 patients with primary HCC were included in this study. All patients agreed to undergo a cfDNA assay on plasma obtained before surgery. The clinical ... See full document
10
Circulating tumor DNA in hepatocellular carcinoma: trends and challenges
... of cfDNA in 1948 ...detect DNA in nanogram, Leon et ...of cfDNA than healthy controls and an increased level after radiation therapy ...of cfDNA as a cancer biomarker, which can also be ... See full document
9
Concordance between genomic alterations assessed by next-generation sequencing in tumor tissue or circulating cell-free DNA
... driver mutation heterogeneity with one study reporting 20/21 known cancer gene mutations in all regions ...contrast, cfDNA only captures mutations above the detection threshold that are found in ... See full document
10
Clinical utility of tumor genomic profiling in patients with high plasma circulating tumor DNA burden or metabolically active tumors
... plasma circulating tumor DNA (ctDNA) have been recommended by the College of American Patholo- gists (CAP), the International Association for the Study of Lung Cancer (IASLC), and the Association for Mo- ... See full document
13
Genetic alteration and mutation profiling of circulating cell-free tumor DNA (cfDNA) for diagnosis and targeted therapy of gastrointestinal stromal tumors
... V600E mutation was detected in 13% (9 of 70) of patients with wild-type KIT/PDGFRA GISTs ...ing mutation in BRAF gene (in approximately 2% of the patients) was found to be consistent with resistance ... See full document
8
Noninvasive prenatal diagnosis of fetal aneuploidy by circulating fetal nucleated red blood cells and extravillous trophoblasts using silicon-based nanostructured microfluidics
... cell-free DNA (cfDNA) in maternal circulation for fetal aneuploidy detection had already achieved widespread recognition and adoption by the clinician community worldwide since 2011 [1, ... See full document
11
Mutational Landscape of cfDNA Identifies Distinct Molecular Features Associated With Therapeutic Response to First-Line Platinum-Based Doublet Chemotherapy in Patients with Advanced NSCLC
... cell-free DNA (cfDNA), released by tumor or normal cells, is a potential surrogate for the genomic information of the whole tumor ...of cfDNA in NSCLC, and proposed cfDNA as a promising ... See full document
10
<p>Current status of liquid biopsies for the detection and management of prostate cancer</p>
... including circulating tumor cells (CTCs), circulating nucleic acids, and exosomes, have been developed as minimally invasive assays allowing oncologists to monitor PC patients with real-time cellular or ... See full document
21
Efficient Genotyping of KRAS Mutant Non-Small Cell Lung Cancer Using a Multiplexed Droplet Digital PCR Approach.
... of KRAS hotspot mutations by ddPCR has been limited by the variety of potential alleles within adjacent loci, although some KRAS mutations occur more commonly in cancer than others (Tables 1 and ...all ... See full document
18
In situ mutation detection and visualization of intratumor heterogeneity for cancer research and diagnostics
... that mutation analysis for molecular cancer diagnostics can be performed directly on tumor tissue ...in KRAS codon 12 and 13 that are associated with resistance to anti-EGFR therapy in colorectal ...the ... See full document
12
Detection of NRAS mutation in cell-free DNA biological fluids from patients with kaposiform lymphangiomatosis
... NRAS mutation was identified in a chest mass in our ...p.Q61R mutation for other KLA and GLA pa- tients who had not undergone WES (genetic) analysis because we did not have fresh frozen samples of their ... See full document
9
Circulating cell-free DNA has a high degree of specificity to detect exon 19 deletions and the single-point substitution mutation L858R in non-small cell lung cancer
... As cfDNA had a high specificity to detect EGFR mutations, cfDNA might be a suitable noninvasive screening test to monitor T790M mutations during TKI treatment ...resistance mutation T790M in ... See full document
12
Tumor mutational burden quantification from targeted gene panels: major advancements and challenges
... cfDNA: Circulating free DNA; CHOL: Cholangiosarcoma; COADREAD: Colon adenocarcinoma; CRC: Colorectal cancer; ctDNA: Circulating tumor DNA; DLBC: Lymphoid neoplasm diffuse large ... See full document
13
Simple and cost effective laboratory methods to evaluate and validate cell free DNA isolation
... cell-free DNA (cfDNA) molecules are shed into bloodstream, plasma, serum, urine as well as other body fluids of humans ...released cfDNA is primarily a consequence of apop- tosis that could be ... See full document
6
A Modified Extraction Method of Circulating Free DNA for Epidermal Growth Factor Receptor Mutation Analysis
... Purpose: Circulating free DNA (cfDNA) in plasma is promising to be a surrogate for tumor tissue ...tissue DNA has been detected in matched cfDNA, at least partly due to ... See full document
6
Related subjects